FDA approval expands earlier use of Enhertu for metastatic breast cancer
The U.S. Food and Drug Administration has approved Enhertu (trastuzumab deruxtecan) for the treatment of adult patients with ...
Leerink Partnrs Has Strong Estimate for ZNTL FY2024 Earnings
Leerink Partnrs boosted their FY2024 earnings per share (EPS) estimates for Zentalis Pharmaceuticals in a research note issued on Wednesday, January 29th. Leerink Partnrs analyst A. Berens now ...